0

    524516

    BACPHAR

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    BACIL PHARMA LTD. Share Price Today

    Investment Returns

    Over 1 Month -32.60% Over 3 Months -49.66% Over 6 Months -30.79% Over 1 Year -24.96%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    BACIL PHARMA LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 38.50
    • P/E Ratio (TTM) 26.11
    • Beta 0.44
    • Book Value / share 17.55
    • Return on equity -0.98%
    • EPS (TTM) 1.08
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.62
    info icon alternate text

    BACIL PHARMA LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.07
    Net Profit 0.62
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.44
    EBITDA 0.04
    Effective Tax Rate (%) -1449.99
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.03
    Net Profit 0.04
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.03
    EBITDA 0.04
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.04
    Net Profit 0.01
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.01
    EBITDA 0.02
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.11
    Net Profit 0.67
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.48
    EBITDA 0.89
    Effective Tax Rate (%) 24.71
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.07
    Net Profit 0.02
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.03
    EBITDA 0.02
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.25
    Net Profit 1.56
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 1.11
    EBITDA 0.99
    Effective Tax Rate (%) -57.57
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.25
    Net Profit 0.40
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.69
    EBITDA 0.41
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.19
    Net Profit -0.06
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.10
    EBITDA -0.06
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.22
    Net Profit -0.10
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.17
    EBITDA -0.10
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.00
    Operating Expense 3.92
    Net Profit -3.86
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -6.55
    EBITDA -3.86
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 18.20
    ROE % -0.98
    ROCE % -1.04
    Total Debt to Total Equity 0.01
    EBITDA Margin 0.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.86
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.05
    EBITDA Margin 0.00
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1.68
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.02
    EBITDA Margin 0.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 1.88
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.08
    EBITDA Margin 0.00
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 2.13
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.13
    EBITDA Margin 0.00
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.85
    Total Assets 25.60
    Total Liabilities 25.60
    Total Equity 25.43
    Share Outstanding 1
    Price to Book Ratio 2.33
    Return on Assets (%) 1.57
    Return on Capital (%) 1.58
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 1.32
    Total Liabilities 1.32
    Total Equity 1.21
    Share Outstanding 0
    Price to Book Ratio 7.87
    Return on Assets (%) -4.45
    Return on Capital (%) -4.5
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 1.12
    Total Liabilities 1.12
    Total Equity 1.09
    Share Outstanding 0
    Price to Book Ratio 3.26
    Return on Assets (%) -9.03
    Return on Capital (%) -9.1
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.22
    Total Assets 1.27
    Total Liabilities 1.27
    Total Equity 1.22
    Share Outstanding 0
    Price to Book Ratio 3.05
    Return on Assets (%) -303.54
    Return on Capital (%) -306.94
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 4.08
    Total Liabilities 4.08
    Total Equity 1.39
    Share Outstanding 0
    Price to Book Ratio 1.46
    Return on Assets (%) -5.85
    Return on Capital (%) -15.27
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.40
    Cash from Operations 0.40
    Cash from Investing 0.33
    Cash from Financing 2.07
    Net change in Cash 2.81
    Free Cash Flow 0.40
    Particulars MAR 2024 (Values in Cr)
    Net Income -0.05
    Cash from Operations 0.00
    Cash from Investing 0.07
    Cash from Financing -0.06
    Net change in Cash 0.01
    Free Cash Flow 0.00
    Particulars MAR 2023 (Values in Cr)
    Net Income -0.10
    Cash from Operations -0.14
    Cash from Investing -0.11
    Cash from Financing 0.06
    Net change in Cash -0.20
    Free Cash Flow -0.14
    Particulars MAR 2022 (Values in Cr)
    Net Income -3.86
    Cash from Operations -4.00
    Cash from Investing 3.81
    Cash from Financing 0.32
    Net change in Cash 0.13
    Free Cash Flow -4.00
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.23
    Cash from Operations -0.39
    Cash from Investing 0.52
    Cash from Financing -0.07
    Net change in Cash 0.05
    Free Cash Flow -0.39
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 32.45 13.46 1.57 248.68 23.12 38.85
    BLISS GVS PHARMA LTD 463.55 37.26 4.12 4916.24 118.35 552.90
    CIPLA LTD. 1410.90 31.85 3.31 113978.90 1165.55 1672.20
    FERMENTA BIOTECH LTD. 432.60 20.23 3.13 1273.18 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2513.25 44.25 18.77 42575.97 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 32.45 22.69 4.18 248.68 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 510.50 22.88 3.98 1475.89 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8000.10 104.55 22.91 20000.25 7630.00 9850.00
    BLISS GVS PHARMA LTD 463.55 50.11 4.25 4916.24 118.35 552.90

    BACIL PHARMA LTD. shareholding pattern

    Holding
    100.0%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    BACIL PHARMA LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    26.79 -5.00 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 31.10
    • 26 Days 37.50
    • 10 Days 33.30
    • 50 Days 41.50
    • 12 Days 34.00
    • 100 Days 44.30
    • 20 Days 36.20
    • 200 Days 43.60
    28.20 PIVOT
    First Support 28.20 First Resistance 28.20 Second Support 28.20 Second Resistance 28.20 Third Support 28.20 Third Resistance 28.20
    RSI 16.51 ADX 22.06 MACD -3.57 Williams % R -100.00 Commodity Channel Index (CCI) -213.73
    Date 2026-07-24 Week 74562.00 Same Day 366.00 Month 121417.00
    1 Year 0.45 3 Year 0.03
    Over 1 Month
    -32.60% down
    Over 1 Year
    -24.96% down
    Over 3 Months
    -49.66% down
    Over 3 Years
    45.89% down
    Over 6 Months
    -30.79% down
    Over 5 Years
    33.50% down

    BACIL PHARMA LTD. Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Bacil Pharma Ltd?

    Answer Field

    Bacil Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 26.79 as on Jul 27 2026 03:19 PM.

    What is the Market Cap of Bacil Pharma Ltd Share?

    Answer Field

    The market cap of Bacil Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 38.50 as on Jul 27 2026 03:19 PM.

    What is the 52 Week High and Low of Bacil Pharma Ltd?

    Answer Field

    The 52 Week High and Low of Bacil Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 61.80 and ₹ 26.69.

    What is 1 year return for Bacil Pharma Ltd?

    Answer Field

    The 1 year returns on the stock has been -24.96%.

    What is the P/E Ratio of Bacil Pharma Ltd Share?

    Answer Field

    As on Jul 27 2026 03:19 PM the price-to-earnings (PE) ratio for Bacil Pharma Ltd share is 26.11.

    What is the PB ratio of Bacil Pharma Ltd Share?

    Answer Field

    As on Jul 27 2026 03:19 PM, the price-to-book (PB) ratio for Bacil Pharma Ltd share is 17.55.

    How to Buy Bacil Pharma Ltd Share?

    Answer Field

    You can trade in Bacil Pharma Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Bacil Pharma Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Bacil Pharma Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Bacil Pharma Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |